|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
 |
|
|
|
|
|
ChiraSource 2002-Europe
"Developments of Speed to Market"
DAY TWO AGENDA
| 8:00am-9:00am |
Registration, Morning Coffee & "Visit the Exhibits" |
|
|
|
|
|
|
|
SESSION II:
State-of-the-Art (cont'd)
| 9:00am |
A Case History of Preliminary Enzyme Screening to Large Scale Synthesis, Dr. Antonella Ursini, GlaxoSmithKline Group
|
| 9:40am |
Crystallization-Induced Dynamic Resolution of an alpha-Amino Ketone as the Key Step in the Synthesis of the Antitumor Agent R116010, Dr. Wim Aelterman, Janssen Pharmacuetica
|
| 10:20am-10:50am |
Morning Coffee & "Visit the Exhibits" |
| 10:50am |
Practical Enantioselective Reduction with Sodium Borohydride, Dr. Takushi Nagata, Mitsui Chemicals, Inc.
|
| 11:30am |
Asymmetric Synthesis of Octahydrobenzochinoline
via Chiral Reductive Amination,
Dr. Olivier Lohse, Novartis Pharma AG
|
| 12:10pm-1:30pm |
Lunch on Own |
| 1:30pm |
Oligomeric Co(Salen) Catalysts: Recent Advances
Dr. Marcello DiMare, Rhodia ChiRex
|
| 2:10pm |
Use of Catalytic Processes for the Production of Pharmaceutical Intermediates,
Dr. Byong-Sung Kwak, SK Corporation
|
| 3:00pm-3:30pm |
Afternoon Break & "Visit the Exhibits" |
|
|
|
|
|
|
|
SESSION III:
New Methods to Speed Development
| 3:30pm |
Degussa's Project Houses - A New Concept to Speed up Development, Dr. Stefan Buchholz, Degussa AG - Project House Biotechnology
|
| 4:00pm |
SMB Separation of Chiral Compounds, Economics and Chemistry, Dr. Yesh P. Sachdeva, Pharm-Eco®, A Johnson Matthey Company
|
|
|
|
|
|
|
|
|
Click here for ChiraSource2002-Europe Day Three Agenda
PLEASE NOTE: This program is accurate as of press time; substitutions may be required in the case of illness or other unforeseen circumstances. The Catalyst Group reserves the right to make these changes.
Back to ChiraSource2002
|
|
|
|
|
|
|
|
|
|
|
|
Copyright ©2002 by The Catalyst Group, Inc., Catalyst Group Resources, Inc., and Catalyst Consultants Publishing. All rights reserved.
|
|
|
|
|
|
|
